Last reviewed · How we verify

NCT04948762

A Contemporary Review of Surgical Approaches in Pelvic Exenterative Surgery

Status unknown Last updated 20 October 2021
What this trial tests

trial in Pelvic Exenteration in 1,000 participants. Status unknown.

Timeline
1 August 2021
Primary endpoint
1 December 2021
1 February 2022

Quick facts

Lead sponsorSt Vincent's University Hospital, Ireland
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment1,000
Start date1 August 2021
Primary completion1 December 2021
Estimated completion1 February 2022
Sites1 location across Ireland

Conditions studied

Sponsor

St Vincent's University Hospital, Ireland

Who can join

18 and older, any sex, with Pelvic Exenteration or Advanced Pelvic Malignancy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Minimally-invasive surgery (MIS) techniques have revolutionised the approach to rectal cancer surgery. With increasing experience, surgeons have began to utilise these platforms increasingly in the context of pelvic exenteration (PE). This observational retrospective review plans to assess the volume of PE being performed on a global basis and to assess the comparative outcomes associated with each technique in order to assess the optimal approach to radical pelvic surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other St Vincent's University Hospital, Ireland trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04948762.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing